HSCI 211 Lecture Notes - Lecture 1: Population Pyramid, Double Burden, Antibiotics

• School: Simon Fraser University
• Department: Health Sciences
• Course: HSCI 211
• Professor: Scott Lear

Document Summary

(cid:862)p(cid:396)olo(cid:374)ged(cid:863), lo(cid:374)g lasti(cid:374)g, lo(cid:374)g te(cid:396)(cid:373), ofte(cid:374) (cid:271)ut (cid:374)ot (cid:374)e(cid:272)essa(cid:396)il(cid:455) i(cid:374)(cid:272)u(cid:396)a(cid:271)le. Any disease that is long lasting or permanent. Often refers to an illness episode greater than 6 weeks: ch(cid:396)o(cid:374)i(cid:272) disease (cid:272)o(cid:374)t(cid:396)ol: Usually refers to conditions not caused by transmissible agents: i(cid:374)(cid:272)ide(cid:374)(cid:272)e, p(cid:396)e(cid:448)ale(cid:374)(cid:272)e, epide(cid:373)iolog(cid:455) (cid:862)the (cid:374)u(cid:373)(cid:271)e(cid:396) of (cid:374)e(cid:449) (cid:272)ases i(cid:374) a spe(cid:272)ifi(cid:272) ti(cid:373)e pe(cid:396)iod(cid:863) (cid:862) the (cid:374)u(cid:373)(cid:271)e(cid:396) of e(cid:454)isti(cid:374)g (cid:272)ases at a gi(cid:448)e(cid:374) ti(cid:373)e(cid:863) The study of the distribution of disease and its determinants. The health outcomes of a group of individuals, including the distribution of such outcomes within the group. To maintain and improve health issues of the entire population. To reduce the inequalities in health status between population groups. A difference in health measurements between groups(distribution of a particular characteristic) regional cvd mortality: health i(cid:374)e(cid:395)uit(cid:455): A difference in measurements between groups that is not only unnecessary and avoidable, but, in addition, is considered unjust (unfair) Prevalence of the disease: p(cid:396)es(cid:272)(cid:396)iptio(cid:374) o(cid:396) poli(cid:272)(cid:455) de(cid:448)elop(cid:373)e(cid:374)t.